{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:01:04Z","timestamp":1780405264995,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,2]]},"DOI":"10.7759\/cureus.110105","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:01:46Z","timestamp":1780401706000},"source":"Crossref","is-referenced-by-count":0,"title":["Artificial Intelligence for Prognostic Modelling and Adaptive Treatment Monitoring in Radiation Oncology"],"prefix":"10.7759","author":[{"given":"Krishna","family":"Chidrawar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep Kaur","family":"Toor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha Mary","family":"Khalkho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"YC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.63125\/matthh09","article-title":"Medical imaging for early cancer diagnosis and epidemiology using artificial intelligence: strengthing national healthcare frameworks in the USA","volume":"2","author":"Alam MA","year":"2023","unstructured":"Alam MA, Sohel A, Hossain A, Eshra SA, Mahmud S. Medical imaging for early cancer diagnosis and epidemiology using artificial intelligence: strengthing national healthcare frameworks in the USA. Am J Sch Res Innov. 2023, 2:24-49. 10.63125\/matthh09","journal-title":"Am J Sch Res Innov"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(20)30185-0","article-title":"Effect of artificial intelligence-based triaging of breast cancer screening mammograms on cancer detection and radiologist workload: a retrospective simulation study","volume":"2","author":"Dembrower K","year":"2020","unstructured":"Dembrower K, W\u00e5hlin E, Liu Y, et al.. Effect of artificial intelligence-based triaging of breast cancer screening mammograms on cancer detection and radiologist workload: a retrospective simulation study. Lancet Digit Health. 2020, 2:e468-74. 10.1016\/S2589-7500(20)30185-0","journal-title":"Lancet Digit Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.53555\/kuey.v30i5.7014","article-title":"Unveiling early detection and prevention of cancer: machine learning and deep learning approaches","volume":"30","author":"Khandakar S","year":"2024","unstructured":"Khandakar S, Al Mamun MA, Islam MM, Hossain K, Melon MM, Javed MS. Unveiling early detection and prevention of cancer: machine learning and deep learning approaches. Educ Adm Theory Pract. 2024, 30:14614-28. 10.53555\/kuey.v30i5.7014","journal-title":"Educ Adm Theory Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215334","article-title":"The role of deep learning in advancing breast cancer detection using different imaging modalities: a systematic review","volume":"14","author":"Madani M","year":"2022","unstructured":"Madani M, Behzadi MM, Nabavi S. The role of deep learning in advancing breast cancer detection using different imaging modalities: a systematic review. Cancers (Basel). 2022, 14:5334. 10.3390\/cancers14215334","journal-title":"Cancers (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.63125\/axcfph56","article-title":"Artificial intelligence-powered medical imaging for early cancer diagnosis and epidemiological analysis: advancing innovation in U.S. national healthcare infrastructure","volume":"4","author":"Alam MA","year":"2025","unstructured":"Alam MA, Alam MF, Alam MF. Artificial intelligence-powered medical imaging for early cancer diagnosis and epidemiological analysis: advancing innovation in U.S. national healthcare infrastructure. Rev Appl Sci Technol. 2025, 4:852-88. 10.63125\/axcfph56","journal-title":"Rev Appl Sci Technol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.210948","article-title":"An artificial intelligence-based mammography screening protocol for breast cancer: outcome and radiologist workload","volume":"304","author":"Lauritzen AD","year":"2022","unstructured":"Lauritzen AD, Rodr\u00edguez-Ruiz A, von Euler-Chelpin MC, et al.. An artificial intelligence-based mammography screening protocol for breast cancer: outcome and radiologist workload. Radiology. 2022, 304:41-9. 10.1148\/radiol.210948","journal-title":"Radiology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.230100","article-title":"Disparities in the demographic composition of the Cancer Imaging Archive","volume":"6","author":"Dulaney A","year":"2024","unstructured":"Dulaney A, Virostko J. Disparities in the demographic composition of the Cancer Imaging Archive. Radiol Imaging Cancer. 2024, 6:e230100. 10.1148\/rycan.230100","journal-title":"Radiol Imaging Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10462-019-09716-5","article-title":"Deep learning-based breast cancer classification through medical imaging modalities: state of the art and research challenges","volume":"53","author":"Murtaza G","year":"2020","unstructured":"Murtaza G, Shuib L, Abdul Wahab AW, et al.. Deep learning-based breast cancer classification through medical imaging modalities: state of the art and research challenges. Artif Intell Rev. 2020, 53:1655-720. 10.1007\/s10462-019-09716-5","journal-title":"Artif Intell Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.30919\/es1859","article-title":"Revolutionizing breast cancer detection with artificial intelligence and machine learning breakthroughs in imaging and diagnosis: literature review","volume":"38","author":"Ramazanova Z","year":"2025","unstructured":"Ramazanova Z, Baiken Y, Matkarimov B, et al.. Revolutionizing breast cancer detection with artificial intelligence and machine learning breakthroughs in imaging and diagnosis: literature review. Eng Sci. 2025, 38:1859. 10.30919\/es1859","journal-title":"Eng Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.17816\/humeco635357","article-title":"Using artificial intelligence to predict and prevent non-cancer mortality in patients with cancer: ARILIS study protocol","volume":"31","author":"Valkov MY","year":"2024","unstructured":"Valkov MY, Grjibovski AM, Kudryavtsev AV, et al.. Using artificial intelligence to predict and prevent non-cancer mortality in patients with cancer: ARILIS study protocol. Hum Ecol. 2024, 31:314-30. 10.17816\/humeco635357","journal-title":"Hum Ecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.24.00133","article-title":"Real-world and clinical trial validation of a deep learning radiomic biomarker for PD-(L)1 immune checkpoint inhibitor response in advanced non-small cell lung cancer","volume":"8","author":"Sako C","year":"2024","unstructured":"Sako C, Duan C, Maresca K, et al.. Real-world and clinical trial validation of a deep learning radiomic biomarker for PD-(L)1 immune checkpoint inhibitor response in advanced non-small cell lung cancer. JCO Clin Cancer Inform. 2024, 8:e2400133. 10.1200\/CCI.24.00133","journal-title":"JCO Clin Cancer Inform"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/srep46349","article-title":"Radiomics-based prognosis analysis for non-small cell lung cancer","volume":"7","author":"Zhang Y","year":"2017","unstructured":"Zhang Y, Oikonomou A, Wong A, Haider MA, Khalvati F. Radiomics-based prognosis analysis for non-small cell lung cancer. Sci Rep. 2017, 7:46349. 10.1038\/srep46349","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2016152234","article-title":"Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer","volume":"281","author":"Huang Y","year":"2016","unstructured":"Huang Y, Liu Z, He L, et al.. Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology. 2016, 281:947-57. 10.1148\/radiol.2016152234","journal-title":"Radiology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15071968","article-title":"Radiomics and delta-radiomics signatures to predict response and survival in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors","volume":"15","author":"Cousin F","year":"2023","unstructured":"Cousin F, Louis T, Dheur S, et al.. Radiomics and delta-radiomics signatures to predict response and survival in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors. Cancers (Basel). 2023, 15:1968. 10.3390\/cancers15071968","journal-title":"Cancers (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0318167","article-title":"Data-driven survival modeling for breast cancer prognostics: a comparative study with machine learning and traditional survival modeling methods","volume":"20","author":"Baidoo TG","year":"2025","unstructured":"Baidoo TG, Rodrigo H. Data-driven survival modeling for breast cancer prognostics: a comparative study with machine learning and traditional survival modeling methods. PLoS One. 2025, 20:e0318167. 10.1371\/journal.pone.0318167","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1147604","article-title":"Time-related survival prediction in molecular subtypes of breast cancer using time-to-event deep-learning-based models","volume":"13","author":"Zarean Shahraki S","year":"2023","unstructured":"Zarean Shahraki S, Azizmohammad Looha M, Mohammadi Kazaj P, et al.. Time-related survival prediction in molecular subtypes of breast cancer using time-to-event deep-learning-based models. Front Oncol. 2023, 13:1147604. 10.3389\/fonc.2023.1147604","journal-title":"Front Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/biology11010047","article-title":"Breast cancer surgery 10-year survival prediction by machine learning: a large prospective cohort study","volume":"11","author":"Lou SJ","year":"2021","unstructured":"Lou SJ, Hou MF, Chang HT, Lee HH, Chiu CC, Yeh SJ, Shi HY. Breast cancer surgery 10-year survival prediction by machine learning: a large prospective cohort study. Biology (Basel). 2021, 11:47. 10.3390\/biology11010047","journal-title":"Biology (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-017-0354-0","article-title":"Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials","volume":"17","author":"Tern\u00e8s N","year":"2017","unstructured":"Tern\u00e8s N, Rotolo F, Michiels S. Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials. BMC Med Res Methodol. 2017, 17:83. 10.1186\/s12874-017-0354-0","journal-title":"BMC Med Res Methodol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10123205","article-title":"Beyond imaging and genetic signature in glioblastoma: radiogenomic holistic approach in neuro-oncology","volume":"10","author":"Gatto L","year":"2022","unstructured":"Gatto L, Franceschi E, Tosoni A, et al.. Beyond imaging and genetic signature in glioblastoma: radiogenomic holistic approach in neuro-oncology. Biomedicines. 2022, 10:3205. 10.3390\/biomedicines10123205","journal-title":"Biomedicines"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13010032","article-title":"Randomized controlled immunotherapy clinical trials for GBM challenged","volume":"13","author":"Van Gool SW","year":"2020","unstructured":"Van Gool SW, Makalowski J, Fiore S, Sprenger T, Prix L, Schirrmacher V, Stuecker W. Randomized controlled immunotherapy clinical trials for GBM challenged. Cancers (Basel). 2020, 13:32. 10.3390\/cancers13010032","journal-title":"Cancers (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17010146","article-title":"Glioblastoma: clinical presentation, multidisciplinary management, and long-term outcomes","volume":"17","author":"Sipos D","year":"2025","unstructured":"Sipos D, Raposa BL, Freihat O, Simon M, Mekis N, Cornacchione P, Kov\u00e1cs \u00c1. Glioblastoma: clinical presentation, multidisciplinary management, and long-term outcomes. Cancers (Basel). 2025, 17:146. 10.3390\/cancers17010146","journal-title":"Cancers (Basel)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-023-04439-8","article-title":"Predicting survival in glioblastoma with multimodal neuroimaging and machine learning","volume":"164","author":"Luckett PH","year":"2023","unstructured":"Luckett PH, Olufawo M, Lamichhane B, et al.. Predicting survival in glioblastoma with multimodal neuroimaging and machine learning. J Neurooncol. 2023, 164:309-20. 10.1007\/s11060-023-04439-8","journal-title":"J Neurooncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-059482","article-title":"Prostate MRI versus PSA screening for prostate cancer detection (the MVP study): a randomised clinical trial","volume":"12","author":"Nam R","year":"2022","unstructured":"Nam R, Patel C, Milot L, et al.. Prostate MRI versus PSA screening for prostate cancer detection (the MVP study): a randomised clinical trial. BMJ Open. 2022, 12:e059482. 10.1136\/bmjopen-2021-059482","journal-title":"BMJ Open"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.07.031","article-title":"Prediction of high-grade prostate cancer following multiparametric magnetic resonance imaging: improving the Rotterdam European Randomized Study of Screening for Prostate Cancer risk calculators","volume":"75","author":"Alberts AR","year":"2019","unstructured":"Alberts AR, Roobol MJ, Verbeek JF, et al.. Prediction of high-grade prostate cancer following multiparametric magnetic resonance imaging: improving the Rotterdam European Randomized Study of Screening for Prostate Cancer risk calculators. Eur Urol. 2019, 75:310-8. 10.1016\/j.eururo.2018.07.031","journal-title":"Eur Urol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002063","article-title":"Improving clinical risk stratification at diagnosis in primary prostate cancer: a prognostic modelling study","volume":"13","author":"Gnanapragasam VJ","year":"2016","unstructured":"Gnanapragasam VJ, Lophatananon A, Wright KA, Muir KR, Gavin A, Greenberg DC. Improving clinical risk stratification at diagnosis in primary prostate cancer: a prognostic modelling study. PLoS Med. 2016, 13:e1002063. 10.1371\/journal.pmed.1002063","journal-title":"PLoS Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03742-z","article-title":"Comparison of MRI artificial intelligence-guided cognitive fusion-targeted biopsy versus routine cognitive fusion-targeted prostate biopsy in prostate cancer diagnosis: a randomized controlled trial","volume":"22","author":"Deng R","year":"2024","unstructured":"Deng R, Liu Y, Wang K, et al.. Comparison of MRI artificial intelligence-guided cognitive fusion-targeted biopsy versus routine cognitive fusion-targeted prostate biopsy in prostate cancer diagnosis: a randomized controlled trial. BMC Med. 2024, 22:530. 10.1186\/s12916-024-03742-z","journal-title":"BMC Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14164012","article-title":"Artificial intelligence predictive models of response to cytotoxic chemotherapy alone or combined to targeted therapy for metastatic colorectal cancer patients: a systematic review and meta-analysis","volume":"14","author":"Russo V","year":"2022","unstructured":"Russo V, Lallo E, Munnia A, et al.. Artificial intelligence predictive models of response to cytotoxic chemotherapy alone or combined to targeted therapy for metastatic colorectal cancer patients: a systematic review and meta-analysis. Cancers (Basel). 2022, 14:4012. 10.3390\/cancers14164012","journal-title":"Cancers (Basel)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105993","article-title":"AI-powered immune profiling from histopathology slides for chemo-radiotherapy outcome prediction in rectal cancer: a study using clinical trial and real-world cohorts","volume":"122","author":"Shen Z","year":"2025","unstructured":"Shen Z, Brand D, Simard M, et al.. AI-powered immune profiling from histopathology slides for chemo-radiotherapy outcome prediction in rectal cancer: a study using clinical trial and real-world cohorts. EBioMedicine. 2025, 122:105993. 10.1016\/j.ebiom.2025.105993","journal-title":"EBioMedicine"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-022-03572-8","article-title":"Combined artificial intelligence and radiologist model for predicting rectal cancer treatment response from magnetic resonance imaging: an external validation study","volume":"47","author":"Horvat N","year":"2022","unstructured":"Horvat N, Veeraraghavan H, Nahas CS, et al.. Combined artificial intelligence and radiologist model for predicting rectal cancer treatment response from magnetic resonance imaging: an external validation study. Abdom Radiol (NY). 2022, 47:2770-82. 10.1007\/s00261-022-03572-8","journal-title":"Abdom Radiol (NY)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102271","article-title":"Deep radiomics-based fusion model for prediction of bevacizumab treatment response and outcome in patients with colorectal cancer liver metastases: a multicentre cohort study","volume":"65","author":"Zhou S","year":"2023","unstructured":"Zhou S, Sun D, Mao W, et al.. Deep radiomics-based fusion model for prediction of bevacizumab treatment response and outcome in patients with colorectal cancer liver metastases: a multicentre cohort study. EClinicalMedicine. 2023, 65:102271. 10.1016\/j.eclinm.2023.102271","journal-title":"EClinicalMedicine"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051228","article-title":"Multitask learning radiomics on longitudinal imaging to predict survival outcomes following risk-adaptive chemoradiation for non-small cell lung cancer","volume":"14","author":"Forouzannezhad P","year":"2022","unstructured":"Forouzannezhad P, Maes D, Hippe DS, et al.. Multitask learning radiomics on longitudinal imaging to predict survival outcomes following risk-adaptive chemoradiation for non-small cell lung cancer. Cancers (Basel). 2022, 14:1228. 10.3390\/cancers14051228","journal-title":"Cancers (Basel)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003605","article-title":"A pre-TACE radiomics model to predict HCC progression and recurrence in liver transplantation: a pilot study on a novel biomarker","volume":"105","author":"Ivanics T","year":"2021","unstructured":"Ivanics T, Salinas-Miranda E, Abreu P, et al.. A pre-TACE radiomics model to predict HCC progression and recurrence in liver transplantation: a pilot study on a novel biomarker. Transplantation. 2021, 105:2435-44. 10.1097\/TP.0000000000003605","journal-title":"Transplantation"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004205","article-title":"Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study","volume":"10","author":"Marinelli B","year":"2022","unstructured":"Marinelli B, Kim E, D'Alessio A, et al.. Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study. J Immunother Cancer. 2022, 10:e004205. 10.1136\/jitc-2021-004205","journal-title":"J Immunother Cancer"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-025-00926-5","article-title":"Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACE","volume":"25","author":"Wei N","year":"2025","unstructured":"Wei N, Mathy RM, Chang DH, et al.. Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACE. Cancer Imaging. 2025, 25:104. 10.1186\/s40644-025-00926-5","journal-title":"Cancer Imaging"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s40537-022-00578-3","article-title":"Predicting clinical outcomes of radiotherapy for head and neck squamous cell carcinoma patients using machine learning algorithms","volume":"9","author":"Gangil T","year":"2022","unstructured":"Gangil T, Shahabuddin AB, Dinesh Rao B, Palanisamy K, Chakrabarti B, Sharan K. Predicting clinical outcomes of radiotherapy for head and neck squamous cell carcinoma patients using machine learning algorithms. J Big Data. 2022, 9:25. 10.1186\/s40537-022-00578-3","journal-title":"J Big Data"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081909","article-title":"MR-guided adaptive radiotherapy for OAR sparing in head and neck cancers","volume":"14","author":"Mulder SL","year":"2022","unstructured":"Mulder SL, Heukelom J, McDonald BA, et al.. MR-guided adaptive radiotherapy for OAR sparing in head and neck cancers. Cancers (Basel). 2022, 14:1909. 10.3390\/cancers14081909","journal-title":"Cancers (Basel)"},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1016\/S0167-8140(24)00529-2","article-title":"Implementation challenges of artificial intelligence-based radiomics in head and neck oncology: a systematic review","volume":"192","author":"Alabi RO","year":"2024","unstructured":"Alabi RO, Almangush A, Elmusrati M, Leivo I, M\u00e4kitie AA. Implementation challenges of artificial intelligence-based radiomics in head and neck oncology: a systematic review. Radiother Oncol. 2024, 192:S207-9.","journal-title":"Radiother Oncol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2024.07.1302","article-title":"Predicting chemoradiotherapy induced cardiotoxicity in breast cancer patients using machine learning based clinical, imaging and dosimetric radiomics features","volume":"120","author":"Tavakoli M","year":"2024","unstructured":"Tavakoli M, Talebi A, Bitarafan-Rajabi A, et al.. Predicting chemoradiotherapy induced cardiotoxicity in breast cancer patients using machine learning based clinical, imaging and dosimetric radiomics features. Int J Radiat Oncol Biol Phys. 2024, 120:e591. 10.1016\/j.ijrobp.2024.07.1302","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2022.12.003","article-title":"Deep learning-based dose prediction for automated, individualized quality assurance of head and neck radiation therapy plans","volume":"13","author":"Gronberg MP","year":"2023","unstructured":"Gronberg MP, Beadle BM, Garden AS, et al.. Deep learning-based dose prediction for automated, individualized quality assurance of head and neck radiation therapy plans. Pract Radiat Oncol. 2023, 13:e282-91. 10.1016\/j.prro.2022.12.003","journal-title":"Pract Radiat Oncol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.829553","article-title":"Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial intelligence and big data","volume":"9","author":"Kwan JM","year":"2022","unstructured":"Kwan JM, Oikonomou EK, Henry ML, Sinusas AJ. Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial intelligence and big data. Front Cardiovasc Med. 2022, 9:829553. 10.3389\/fcvm.2022.829553","journal-title":"Front Cardiovasc Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/s40959-022-00151-0","article-title":"Patient similarity and other artificial intelligence machine learning algorithms in clinical decision aid for shared decision-making in the Prevention of Cardiovascular Toxicity (PACT): a feasibility trial design","volume":"9","author":"Brown SA","year":"2023","unstructured":"Brown SA, Chung BY, Doshi K, et al.. Patient similarity and other artificial intelligence machine learning algorithms in clinical decision aid for shared decision-making in the Prevention of Cardiovascular Toxicity (PACT): a feasibility trial design. Cardiooncology. 2023, 9:7. 10.1186\/s40959-022-00151-0","journal-title":"Cardiooncology"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-022-03341-y","article-title":"An artificial intelligence approach for predicting cardiotoxicity in breast cancer patients receiving anthracycline","volume":"96","author":"Chang WT","year":"2022","unstructured":"Chang WT, Liu CF, Feng YH, et al.. An artificial intelligence approach for predicting cardiotoxicity in breast cancer patients receiving anthracycline. Arch Toxicol. 2022, 96:2731-7. 10.1007\/s00204-022-03341-y","journal-title":"Arch Toxicol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s44411-025-00312-4","article-title":"Challenges in the clinical application of machine learning for pancreatic cancer","volume":"126","author":"Ve\u010durkovsk\u00e1 I","year":"2025","unstructured":"Ve\u010durkovsk\u00e1 I, Ro\u0161kovi\u010dov\u00e1 V, Ka\u0165uchov\u00e1 J. Challenges in the clinical application of machine learning for pancreatic cancer. Bratisl Med J. 2025, 126:2437-50. 10.1007\/s44411-025-00312-4","journal-title":"Bratisl Med J"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2025.26.12.4299","article-title":"Precision medicine and artificial intelligence in next-generation cancer surgery: a comprehensive analysis of clinical applications, therapeutic outcomes, and implementation strategies","volume":"26","author":"Negahi A","year":"2025","unstructured":"Negahi A, Khosravi-Mashizi M, Najdsepas H, et al.. Precision medicine and artificial intelligence in next-generation cancer surgery: a comprehensive analysis of clinical applications, therapeutic outcomes, and implementation strategies. Asian Pac J Cancer Prev. 2025, 26:4299-312. 10.31557\/APJCP.2025.26.12.4299","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK-25-100048","article-title":"Driving knowledge to action: building a better future with artificial intelligence-enabled multidisciplinary oncology","volume":"45","author":"Loaiza-Bonilla A","year":"2025","unstructured":"Loaiza-Bonilla A, Thaker N, Chung C, Parikh RB, Stapleton S, Borkowski P. Driving knowledge to action: building a better future with artificial intelligence-enabled multidisciplinary oncology. Am Soc Clin Oncol Educ Book. 2025, 45:e100048. 10.1200\/EDBK-25-100048","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3389\/fnetp.2025.1578562","article-title":"Evaluation of deep learning tools in medical diagnosis and treatment of cancer: research analysis of clinical and randomized clinical trials","volume":"5","author":"Hodeify R","year":"2025","unstructured":"Hodeify R. Evaluation of deep learning tools in medical diagnosis and treatment of cancer: research analysis of clinical and randomized clinical trials. Front Netw Physiol. 2025, 5:1578562. 10.3389\/fnetp.2025.1578562","journal-title":"Front Netw Physiol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02256-1","article-title":"China Protocol for early screening, precise diagnosis, and individualized treatment of lung cancer","volume":"10","author":"Wang C","year":"2025","unstructured":"Wang C, Chen B, Liang S, et al.. China Protocol for early screening, precise diagnosis, and individualized treatment of lung cancer. Signal Transduct Target Ther. 2025, 10:175. 10.1038\/s41392-025-02256-1","journal-title":"Signal Transduct Target Ther"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1622060","article-title":"Recent technical advancements and clinical applications of MR-guided radiotherapy in lung cancer treatment","volume":"15","author":"Ma C","year":"2025","unstructured":"Ma C, Wang X, Nie K, Xiong Z, Xu K, Yue N, Zhang Y. Recent technical advancements and clinical applications of MR-guided radiotherapy in lung cancer treatment. Front Oncol. 2025, 15:1622060. 10.3389\/fonc.2025.1622060","journal-title":"Front Oncol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1612376","article-title":"Integrating artificial intelligence with circulating tumor DNA for non-small cell lung cancer: opportunities, challenges, and future directions","volume":"12","author":"Thalambedu N","year":"2025","unstructured":"Thalambedu N, Balla M, Sivasubramanian BP, Sadaram P, Malla KP, Vasipalli KP, Kakadia S. Integrating artificial intelligence with circulating tumor DNA for non-small cell lung cancer: opportunities, challenges, and future directions. Front Med (Lausanne). 2025, 12:1612376. 10.3389\/fmed.2025.1612376","journal-title":"Front Med (Lausanne)"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1486310","article-title":"Artificial intelligence in lung cancer: current applications, future perspectives, and challenges","volume":"14","author":"Huang D","year":"2024","unstructured":"Huang D, Li Z, Jiang T, Yang C, Li N. Artificial intelligence in lung cancer: current applications, future perspectives, and challenges. Front Oncol. 2024, 14:1486310. 10.3389\/fonc.2024.1486310","journal-title":"Front Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/492572-artificial-intelligence-for-prognostic-modelling-and-adaptive-treatment-monitoring-in-radiation-oncology","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:01:47Z","timestamp":1780401707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/492572-artificial-intelligence-for-prognostic-modelling-and-adaptive-treatment-monitoring-in-radiation-oncology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.110105","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,2]]}}}